US Bancorp’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-54
| Closed | -$4K | – | 4330 |
|
|
2022
Q3 | $4K | Buy |
54
+10
| +23% | +$741 | ﹤0.01% | 3678 |
|
|
2022
Q2 | $1K | Sell |
44
-359
| -89% | -$8.16K | ﹤0.01% | 4023 |
|
|
2022
Q1 | $14K | Sell |
403
-840
| -68% | -$29.2K | ﹤0.01% | 3251 |
|
|
2021
Q4 | $37K | Sell |
1,243
-142
| -10% | -$4.23K | ﹤0.01% | 2799 |
|
|
2021
Q3 | $36K | Buy |
1,385
+478
| +53% | +$12.4K | ﹤0.01% | 2815 |
|
|
2021
Q2 | $32K | Buy |
907
+654
| +258% | +$23.1K | ﹤0.01% | 2885 |
|
|
2021
Q1 | $10K | Sell |
253
-153
| -38% | -$6.05K | ﹤0.01% | 3288 |
|
|
2020
Q4 | $18K | Sell |
406
-1,068
| -72% | -$47.4K | ﹤0.01% | 2954 |
|
|
2020
Q3 | $81K | Buy |
1,474
+36
| +3% | +$1.98K | ﹤0.01% | 2177 |
|
|
2020
Q2 | $91K | Buy |
1,438
+693
| +93% | +$43.9K | ﹤0.01% | 2136 |
|
|
2020
Q1 | $38K | Sell |
745
-11
| -1% | -$561 | ﹤0.01% | 2422 |
|
|
2019
Q4 | $60K | Buy |
756
+745
| +6,773% | +$59.1K | ﹤0.01% | 2385 |
|
|
2019
Q3 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 3540 |
|
|
2019
Q2 | – | Sell |
-209
| Closed | -$11K | – | 3711 |
|
|
2019
Q1 | $11K | Sell |
209
-257
| -55% | -$13.5K | ﹤0.01% | 3044 |
|
|
2018
Q4 | $19K | Sell |
466
-529
| -53% | -$21.6K | ﹤0.01% | 2838 |
|
|
2018
Q3 | $38K | Hold |
995
| – | – | ﹤0.01% | 2692 |
|
|
2018
Q2 | $45K | Buy |
+995
| New | +$45K | ﹤0.01% | 2631 |
|
|
2018
Q1 | – | Sell |
-162
| Closed | -$6K | – | 3730 |
|
|
2017
Q4 | $6K | Buy |
+162
| New | +$6K | ﹤0.01% | 3295 |
|